53 results
Page 2 of 3
8-K
EX-10.1
sz88om1odl mo2135t
5 Jul 22
Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board of Directors
4:41pm
DEFC14C
lecap
2 Jun 22
Information statement in contested solicitation
4:24pm
PRER14C
bk5y1
31 May 22
Preliminary revised information
5:09pm
PREC14C
0ohu9v10 fnwwz156k7
19 May 22
Preliminary information statement in contested solicitation
5:05pm
10-K/A
ud4olpi90ln
29 Apr 22
Annual report (amended)
4:43pm
PREC14A
zpecqcn 4drrtbapjc
26 Apr 22
Preliminary proxy with contested solicitation
8:48am
10-K
EX-10.11
zv13ck
31 Mar 22
Annual report
8:18am
10-K
egtez5mxb3cj5qas
31 Mar 22
Annual report
8:18am
8-K
EX-99.1
016dhqo0xb h9m
21 Mar 22
Departure of Directors or Certain Officers
6:32am
8-K/A
EX-99.1
82ou2
21 Mar 22
Departure of Directors or Certain Officers
6:30am
8-K
EX-99.1
fcgyt uesuv
14 Dec 21
Adagio Therapeutics Reports Reduction in In Vitro Neutralizing Activity of ADG20 Against Omicron SARS-CoV-2 Variant
9:10am
10-Q
EX-10.5
445332kf2f2tje5l59
20 Sep 21
Quarterly report
4:17pm
10-Q
EX-10.7
ulrus7
20 Sep 21
Quarterly report
4:17pm
10-Q
EX-10.6
qwnvcez
20 Sep 21
Quarterly report
4:17pm
8-K
EX-99.1
w4nc9xenb11 z4k
20 Sep 21
Adagio Therapeutics Provides COVID-19 Antibody Program Updates as well as Business
4:05pm
424B4
63w2vv 6m
6 Aug 21
Prospectus supplement with pricing info
4:54pm